Regeneron Pharmaceuticals Inc. / Ophthalmology Regeneron Pharmaceuticals Inc. / AMD / Sponsor Presentation Regeneron Pharmaceuticals Inc. / D. Chief Scientific Officer Regeneron Pharmaceuticals Inc. / M.B.A. / /
Facility
Ophthalmic Drugs Advisory Committee Marriott Inn / Conference Center University of Maryland University College / Tufts University / Cleveland Clinic Lerner College / Cole Eye Institute / /
IndustryTerm
aflibercept ophthalmic solution / /
MedicalCondition
macular degeneration / /
Organization
Cole Eye Institute / Division of Transplant / School of Medicine Clinical / Center for Drug Evaluation & Research / office of New Drugs / Food and Drug Administration / Introductions Michael Repka / M.D. Committee Chair Dermatologic and Ophthalmic Drugs Advisory Committee / FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH Dermatologic / Harvard / Cleveland Clinic Lerner College of Medicine Vitreoretinal Surgeon Cole Eye Institute / FDA / University of Maryland University College / Digital Coherence Tomography Reading Center / Tufts University / office of Antimicrobial Products / /
Person
Pharmacology Neil Stahl / Ph.D. Sr. / Efficacy Robert Vitti / Michael Repka / Yvette Waples / Sonal Wadhwa / Need Jeffrey Heier / George Yancopoulos / Safety Ned Braunstein / /
Position
Professor of Ophthalmology / Federal Officer / Executive Director Regulatory Affairs / Deputy Director / Founding Director / Cleveland Clinic / Vitreoretinal Specialist / Boston Assistant / Vice President Clinical Sciences / Sr. Vice President Research and Development Sciences / /
The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus